Acadian Asset Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-241,507
| Closed | -$252K | – | 2209 |
|
|
2019
Q1 | $252K | Buy |
241,507
+46,400
| +24% | +$48.4K | ﹤0.01% | 1298 |
|
|
2018
Q4 | $146K | Buy |
195,107
+40,353
| +26% | +$30.2K | ﹤0.01% | 1186 |
|
|
2018
Q3 | $329K | Buy |
154,754
+16,263
| +12% | +$34.6K | ﹤0.01% | 973 |
|
|
2018
Q2 | $320K | Buy |
138,491
+81,698
| +144% | +$189K | ﹤0.01% | 969 |
|
|
2018
Q1 | $181K | Buy |
+56,793
| New | +$181K | ﹤0.01% | 1083 |
|
|
2017
Q2 | – | Sell |
-31,353
| Closed | -$289K | – | 1766 |
|
|
2017
Q1 | $289K | Buy |
+31,353
| New | +$289K | ﹤0.01% | 983 |
|